Search Results - (Author, Cooperation:S. Matsuda)
-
1Teoh, A. Y. B., Dhir, V., Kida, M., Yasuda, I., Jin, Z. D., Seo, D. W., Almadi, M., Ang, T. L., Hara, K., Hilmi, I., Itoi, T., Lakhtakia, S., Matsuda, K., Pausawasdi, N., Puri, R., Tang, R. S., Wang, H.-P., Yang, A. M., Hawes, R., Varadarajulu, S., Yasuda, K., Ho, L. K. Y.
BMJ Publishing Group
Published 2018Staff ViewPublication Date: 2018-06-08Publisher: BMJ Publishing GroupPrint ISSN: 0017-5749Electronic ISSN: 1468-3288Topics: MedicineKeywords: GutPublished by: -
2Staff View
Publication Date: 2018-05-18Publisher: American Society of Hematology (ASH)Print ISSN: 0006-4971Electronic ISSN: 1528-0020Topics: BiologyMedicineKeywords: Free Research Articles, BloodWork, Myeloid Neoplasia, Lymphoid NeoplasiaPublished by: -
3Koda, H., Murai, T., Tuuga, A., Goossens, B., Nathan, S. K. S. S., Stark, D. J., Ramirez, D. A. R., Sha, J. C. M., Osman, I., Sipangkui, R., Seino, S., Matsuda, I.
American Association for the Advancement of Science (AAAS)
Published 2018Staff ViewPublication Date: 2018-02-22Publisher: American Association for the Advancement of Science (AAAS)Electronic ISSN: 2375-2548Topics: Natural Sciences in GeneralPublished by: -
4Y. Ito ; M. Hashimoto ; K. Hirota ; N. Ohkura ; H. Morikawa ; H. Nishikawa ; A. Tanaka ; M. Furu ; H. Ito ; T. Fujii ; T. Nomura ; S. Yamazaki ; A. Morita ; D. A. Vignali ; J. W. Kappler ; S. Matsuda ; T. Mimori ; N. Sakaguchi ; S. Sakaguchi
American Association for the Advancement of Science (AAAS)
Published 2014Staff ViewPublication Date: 2014-10-18Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsKeywords: Animals ; Arthritis, Rheumatoid/genetics/*immunology ; Autoantigens/*immunology ; Autoimmunity/*immunology ; DNA-Binding Proteins/genetics ; Gene Expression Regulation ; Genes, T-Cell Receptor beta ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Mutant Strains ; Receptors, Antigen, T-Cell/*immunology ; Ribosomal Proteins/genetics/*immunology ; T-Lymphocytes/*immunologyPublished by: -
5K. Nagao ; R. Okazaki ; T. Nakamura ; Y. N. Miura ; T. Osawa ; K. Bajo ; S. Matsuda ; M. Ebihara ; T. R. Ireland ; F. Kitajima ; H. Naraoka ; T. Noguchi ; A. Tsuchiyama ; H. Yurimoto ; M. E. Zolensky ; M. Uesugi ; K. Shirai ; M. Abe ; T. Yada ; Y. Ishibashi ; A. Fujimura ; T. Mukai ; M. Ueno ; T. Okada ; M. Yoshikawa ; J. Kawaguchi
American Association for the Advancement of Science (AAAS)
Published 2011Staff ViewPublication Date: 2011-08-27Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsPublished by: -
6R O Kuzian, R Klingeler, W E A Lorenz, N Wizent, S Nishimoto, U Nitzsche, H Rosner, D Milosavljevic, L Hozoi, R Yadav, J Richter, A Hauser, J Geck, R Hayn, V Yushankhai, L Siurakshina, C Monney, T Schmitt, J Thar, G Roth, T Ito, H Yamaguchi, M Matsuda, S Johnston, J Málek and S-L Drechsler
Institute of Physics (IOP)
Published 2018Staff ViewPublication Date: 2018-05-19Publisher: Institute of Physics (IOP)Electronic ISSN: 1367-2630Topics: PhysicsPublished by: -
7Matsuoka, M. ; Akiba, M. ; Arimoto, K. ; Horiike, H. ; Kuriyama, M. ; Matsuda, S. ; Ohara, Y.
[S.l.] : American Institute of Physics (AIP)
Published 1990Staff ViewISSN: 1089-7623Source: AIP Digital ArchiveTopics: PhysicsElectrical Engineering, Measurement and Control TechnologyNotes: Capability of beam-energy control during a beam pulse has been demonstrated in the JT-60 neutral beam injection system. In addition to the acceleration voltage, the acceleration current and magnetic field separating residual ion beams were simultaneously varied. A preprogram control was adopted to cope with the relatively long time constant of the magnetic field due to the eddy current induced in the magnet core. The overall time constant is about 0.4 s. Beam-energy control was first tested in the prototype injector unit for JT-60 and then applied in JT-60 heating experiments. By advancing the idea demonstrated here, it is possible to design future neutral beam systems with real-time beam-energy control that follows target plasma evolutions.Type of Medium: Electronic ResourceURL: -
8SAIDA, T. ; SAIDA, K. ; FUNAUCHI, M. ; NISHIGUCHI, E. ; NAKAJIMA, M. ; MATSUDA, S. ; OHTA, M. ; OHTA, K. ; NISHITANI, H. ; HATANAKA, M.
Oxford, UK : Blackwell Publishing Ltd
Published 1988Staff ViewISSN: 1749-6632Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: Natural Sciences in GeneralType of Medium: Electronic ResourceURL: -
9Nagakura, T. ; Obata, T. ; Shichijo, K. ; Matsuda, S. ; Sigimoto, H. ; Yamashita, K. ; Masaki, T. ; Maekawa, K.
Oxford BSL : Blackwell Science Ltd
Published 1998Staff ViewISSN: 1365-2222Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: 9α,11β-Prostaglandin (PG) F2 is an initial metabolite of PGD2 which has a potent bronchoconstrictive activity.〈section xml:id="abs1-2"〉〈title type="main"〉ObjectivesWe measured the urinary levels of 9α,11β-PGF2 in asthmatic children to investigate its role in not only acute asthmatic attack in a time course study but also in exercise-induced asthma (EIA).〈section xml:id="abs1-3"〉〈title type="main"〉MethodsIn the acute asthma study, 30 asthmatic children were examined. Urine samples were collected on the first, third, and sixth days. Urinary levels of 9α,11β-PGF2 were measured with gas chromatography mass spectrometry using the electron impact method. In the exercise challenge study, 14 children with EIA and 14 children without EIA were studied. Urine samples were collected before exercise challenge, and at 1 h, and 5 h after exercise challenge. Urinary levels of 9α,11β-PGF2 were measured.〈section xml:id="abs1-4"〉〈title type="main"〉ResultsElevated urinary levels of 9α,11β-PGF2, which were observed on the first day when treatment was started in the hospital, were gradually decreased on the third day (P 〈 0.05), and on the sixth day (P 〈 0.01). A significant correlation between urinary levels of 9α,11β-PGF2 and symptom scores (P 〈 0.005) was observed on the first day. In EIA, there was a significant increase in urinary levels of 9α,11β-PGF2 at 1 h (P 〈 0.01) and at 5 h (P 〈 0.01) after exercise challenge, but not in the children without EIA.〈section xml:id="abs1-5"〉〈title type="main"〉Conclusion9α,11β-PGF2 may be involved in the pathogenesis of acute and exercise-induced asthma in children.Type of Medium: Electronic ResourceURL: -
10Fukuhara, C. ; Matsuda, S. ; Katsura, K. ; Mori, M. ; Matsumoto, K. ; Ooi, S. ; Yoshikawa, Y.
Amsterdam : ElsevierStaff ViewISSN: 0020-1693Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: Chemistry and PharmacologyType of Medium: Electronic ResourceURL: -
11Oda, Y ; Takahira, T ; Kawaguchi, K ; Yamamoto, H ; Tamiya, S ; Matsuda, S ; Tanaka, K ; Iwamoto, Y ; Tsuneyoshi, M
Oxford, UK : Blackwell Science Ltd
Published 2004Staff ViewISSN: 1365-2559Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Aims: Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive variant of fibrosarcoma and has been reported to have metastatic potential despite its low-grade histological findings. Low-grade myxofibrosarcoma (MFS) is an important differential diagnosis of LGMFS, because it shows different biological behaviour. Of 75 MFSs in the extremities and trunk, we defined 22 grade 1 tumours as low-grade MFS according to the French Federation of Cancer Centres grading system and compared the clinicopathological factors and immunohistochemical expression of cell cycle regulators with those of 11 LGFMSs.Methods and results: The two entities could be distinguished on histological grounds. Low-grade MFS was characterized by the presence of prominent elongated, curvilinear capillaries and pseudolipoblasts, accompanied by an abundant myxoid matrix. It had no extensive solid areas. LGFMS was composed of bland spindle cells arranged in a whorled pattern with alternating myxoid and fibrous stroma. Curvilinear capillaries were not prominent and cytological atypia was absent. No tumour necrosis was observed in any of the 11 LGFMSs, whereas only one case showed tumour necrosis in less than 50% of the tumour in 22 low-grade MFSs. The patients with low-grade MFS were significantly older than those with LGFMS (low-grade MFS average, 60.1 years; LGFMS average, 31.5 years; P 〈 0.0001) and low-grade MFS occurred more frequently in a superficial location (low-grade MFS 14/20; LGFMS 2/11; P = 0.0077). As for cell cycle regulator expression, the MIB-1 labelling index (LI) (14.76 on average) and cyclin E LI (11.55 on average) in low-grade MFS were significantly higher than those (MIB-1 LI, 4.68 on average; cyclin E LI, 3.38 on average) of LGFMS, while p21 LI (25.53 on average) and p27 LI (42.68 on average) in low-grade MFS were significantly lower than those (p21 LI, 42.74 on average; p27 LI, 57.28 on average) of LGFMS.Conclusions: We conclude that low-grade MFS and LGFMS are distinctly different clinicopathological entities and the assessment of the immunohistochemical expression of MIB-1, cyclin E, p21 and p27 as well as conventional clinicopathological features may be helpful to distinguish low-grade MFS from LGFMS.Type of Medium: Electronic ResourceURL: -
12Oda, Y ; Sakamoto, A ; Saito, T ; Matsuda, S ; Tanaka, K ; Iwamoto, Y ; Tsuneyoshi, M
Oxford UK : Blackwell Science Ltd
Published 2001Staff ViewISSN: 1365-2559Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation Aims: We report two cases of secondary malignant giant-cell tumour occurring without irradiation therapy. To elucidate the mechanism of malignant transformation in this tumour, we searched for the molecular abnormalities of p53, MDM2 and the H-ras genes. Methods and results: These cases were retrieved after a review of 103 cases of primary giant-cell tumour of bone, registered in our institute. One case occurred in the distal femur of a 42-year-old female after surgical curettage, while the other arose in the acetabulum of a 25-year-old male after en bloc resection. Microscopically, the malignant tumour in the distal femur was composed of a proliferation of ovoid or fusiform cells arranged in fascicles with high mitotic activities. The malignant transformed tumour in the acetabulum was made up of pleomorphic tumour cells with atypical mitoses. In the tumour of the distal femur, both p53 and H-ras mutations were detected. Abnormal nuclear accumulation of p53 protein and c-myc expression were also revealed by immunohistochemistry. In both cases, the recurrent malignant tumour over-expressed MMP-9 and revealed a higher MIB-1-labelling index compared with the primary conventional giant-cell tumour. Conclusions: Our results suggest that multiple oncogene or tumour suppressor gene mutations may play an important role during malignant transformation in conventional giant-cell tumours.Type of Medium: Electronic ResourceURL: -
13Hada, T. ; Hagiya, H. ; Suzuki, H. ; Arakawa, T. ; Nakamura, M. ; Matsuda, S. ; Yoshimoto, T. ; Yamamoto, S. ; Kim, H.-y. ; Ishimura, K. ; Azekawa, T. ; Morita, Y.
Amsterdam : ElsevierStaff ViewISSN: 0005-2760Keywords: (Rat) ; Lipoxygenase ; Pineal gland ; Primary structureSource: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: BiologyChemistry and PharmacologyMedicinePhysicsType of Medium: Electronic ResourceURL: -
14Sano, A. ; Matsuda, S. ; Wen, T.C. ; Kotani, Y. ; Kondoh, K. ; Ueno, S. ; Kakimoto, Y. ; Yoshimura, H. ; Sakanaka, M.
Amsterdam : ElsevierStaff ViewISSN: 0006-291XSource: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: BiologyChemistry and PharmacologyPhysicsType of Medium: Electronic ResourceURL: -
15Staff View
ISSN: 0920-5632Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: PhysicsType of Medium: Electronic ResourceURL: -
16Araki, M. ; Dairaku, M. ; Inoue, T. ; Komata, M. ; Kuriyama, M. ; Matsuda, S. ; Ogawa, M. ; Ohara, Y. ; Yokoyama, K. ; Seki, M.
Amsterdam : ElsevierStaff ViewISSN: 0920-3796Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: Energy, Environment Protection, Nuclear Power EngineeringPhysicsType of Medium: Electronic ResourceURL: -
17Kuriyama, M. ; Araki, M. ; Horiike, H. ; Matsuda, S. ; Matsuoka, M. ; Ohara, Y. ; Okumura, Y. ; Shibanuma, K. ; Shirakata, H. ; Tanaka, S.
Amsterdam : ElsevierStaff ViewISSN: 0920-3796Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: Energy, Environment Protection, Nuclear Power EngineeringPhysicsType of Medium: Electronic ResourceURL: -
18Matsuda, S. ; Akiba, M. ; Araki, M. ; Dairaku, M. ; Ebisawa, N. ; Horiike, H. ; Itoh, T. ; Kanai, T. ; Ohhara, H. ; Shirakata, H. ; Mizuhashi, K. ; Shibanuma, K. ; Watanabe, K. ; Kawai, M. ; Komata, M. ; Kuriyama, M. ; Matsuoka, M. ; Kitamura, S. ; Tanaka, S. ; Ohga, T. ; Shibata, T. ; Sugawara, T. ; Ohara, Y. ; Ohuchi, Y. ; Okumura, Y.
Amsterdam : ElsevierStaff ViewISSN: 0920-3796Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: Energy, Environment Protection, Nuclear Power EngineeringPhysicsType of Medium: Electronic ResourceURL: -
19Staff View
ISSN: 0921-4534Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: PhysicsType of Medium: Electronic ResourceURL: -
20Staff View
ISSN: 0921-4534Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: PhysicsType of Medium: Electronic ResourceURL: